| Gene symbol | TNFRSF8 | Synonyms | CD30, D1S166E, Ki-1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p36.22 | dbXrefs | |
| Description | TNF receptor superfamily member 8 | ||||
| GTO ID | GTC0956 |
| Trial ID | ChiCTR2100053662 |
| Disease | Lymphoproliferative Syndrome |
| Altered gene | CD30 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD30 CAR-T cells |
| Co-treatment | auto-HSCT |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | An open label, single center, single arm clinical study for infusion of anti-CD30 CAR-T therapy following autologous hematopoietic stem cell transplantation (auto-HSCT) for relapsed, refractory and high-risk CD30-positive lymphoproliferative disorders |
| Year | 2021 |
| Country | China |
| Company sponsor | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| Cohort 1 | |||||||
|
|||||||